Oils4cure: finding an effective drug to alleviate Refractory Epilepsy, one of the most severe symptoms in the pathology of Tuberous Sclerosis Complex

Project Information

oils4cure

Grant agreement ID: 190119321

DOI

10.3030/190119321

EC signature date 30 November 2023

Start date 1 December 2023

End date 31 August 2026

Funded under

• The European Innovation Council (EIC)

Total cost

€ 2 225 538,75

EU contribution

€ 1 557 877,13

Coordinated by

OILS4CURE SL
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (3)

Zero patient recruitment

Patient information documents will be delivered to the participants. The informed consent documents will be collected. The seizure collection diary and definition and classification of the types of seizures according to the Spanish League against Epilepsy (ILAE) will be delivered. The regulatory agency will be informed of the initiation of the recruitment so that the active trial status can be recorded in the Spanish clinical trial registry.https://reec.aemps.es/reec/public/detail.html

Capital issuance
Search report

Search report from subcontractor

Websites, patent fillings, videos etc. (2)

Website
Promotional video